TFG Asset Management Increases Stake in Synairgen
I'm PortAI, I can summarize articles.
TFG Asset Management UK LLP has increased its stake in Synairgen PLC, now holding 86.881% of the voting rights, up from 28.154%. This significant acquisition may enhance Synairgen's market position and influence its future strategies. Synairgen is a UK biotechnology firm focused on developing treatments for respiratory diseases. The company's current market cap is £9.99M, with a year-to-date price performance of -26.22%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments